DanielAlmquistMD

PubMed

• 1 citations
  Chemoimmunotherapy as the First-Line Treatment for Patients With Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3.
  Muskan Agarwal, Alex Liu, Blake T Langlais, Konstantinos Leventakos, Nathan Y Yu, Daniel Almquist, Rami Manochakian, Vinicius Ernani> ;Clinical Lung Cancer. 2023 Nov 1
• 4 citations
  Treatment landscape of advanced high-grade neuroendocrine neoplasms.
  Samee Zane Alheraki, Daniel R Almquist, Jason S Starr, Thorvardur R Halfdanarson, Mohamad Bassam Sonbol> ;Clinical Advances in Hematology & Oncology. 2023 Jan 1
• The not so small role of adjuvant chemotherapy in resected non-small cell lung cancer
  Daniel R. Almquist, Panayiotis Savvides, Vinicius Ernani> ;Jornal Brasileiro De Pneumologia. 2021 Jul 12
• 1 citations
  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: DIPNECH.
  Daniel R. Almquist, Vinicius Ernani, Mohamad Bassam Sonbol> ;Current Opinion in Pulmonary Medicine. 2021 Apr 28
• 5 citations
  Clinical Characteristics of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: A Retrospective Analysis.
  Daniel R. Almquist, Mohamad Bassam Sonbol, Helen J. Ross, Heidi E. Kosiorek, Dawn E. Jaroszewski, Thorvardur R. Halfdanarson> ;Chest. 2021 Jan 1
• 4 citations
  The Road Less Traveled: A Guide to Metastatic ROS1-Rearranged Non-Small-Cell Lung Cancer.
  Daniel R. Almquist, Vinicius Ernani> ;JCO Oncology Practice. 2021 Jan 1
• 112 citations
  Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-analysis
  Mohamad Bassam Sonbol, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Daniel R. Almquist, Syeda A. Mina, Jehad Almasri, Shiv Shah, Diana Almader-Douglas, Pedro Luiz Serrano...> ;JAMA Oncology. 2020 Dec 1
• Change in 21-gene Recurrence Score result after exposure to neo-adjuvant endocrine therapy in patients with operable breast cancer.
  Talal Hilal, Lanyu Mi, Natalie Ertz-Archambault, Daniel R. Almquist, Karen S. Anderson, Richard Gray, Barbara A. Pockaj, Donald W. Northfelt> ;The Breast Journal. 2020 Jul 1
• 9 citations
  Somatostatin Analogs Improve Respiratory Symptoms in Patients With Diffuse Idiopathic Neuroendocrine Cell Hyperplasia
  Taymeyah Al-Toubah, Jonathan R. Strosberg, Thorvardur R. Halfdanarson, Kira Oleinikov, David J. Gross, Mintallah Haider, Mohamad Bassam Sonbol, Daniel R. Almquist, Sim...> ;Chest. 2020 Jul 1
• 28 citations
  The Role of Immune Checkpoint Inhibitors in Colorectal Adenocarcinoma
  Daniel R. Almquist, Daniel H. Ahn, Tanios Bekaii-Saab> ;Biodrugs. 2020 Jun 1
• 15 citations
  Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations.
  Thomas DeLeon, Daniel R. Almquist, Benjamin R. Kipp, Blake T. Langlais, Aaron R. Mangold, Jennifer L. Winters, Heidi E. Kosiorek, Richard W. Joseph, Roxana S. Dronca, ...> ;Plos One. 2020 Mar 20
• 2 citations
  Sequential HER2-Targeted Therapy in Salivary Ductal Carcinoma With HER2/neu Overexpression and a Concomitant ERBB2 Mutation
  Daniel Almquist, Jayadev Manikkam Umakanthan, Apar Kishor Ganti> ;JCO Precision Oncology. 2018 May 17
• 10 citations
  Preoperative Pulmonary Function Tests (PFTs) and Outcomes from Resected Early Stage Non-small Cell Lung Cancer (NSCLC).
  Daniel Almquist, Nabin Khanal, Lynette M. Smith, Apar Kishor Ganti> ;Anticancer Research. 2018 May 1
• Join now to see all

Abstracts/Posters

• Proton Pump Inhibitors Associated with Higher Incidence of Mucositis in Patients Receiving Methotrexate for Graft Vs Host Disease Prophylaxis
  Daniel Almquist, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• DIPNECH: The Mayo experience. 
  2019 ASCO Annual Meeting - 6/1/2019